You are carrying out studies with a drug to potentially treat the hyperglycemia of Type 2 diabetes. Your studies find that in cell culture this drug induces the activity of peroxisome proliferatoractivated receptor-g (PPARg). These results indicate that your experimental drug is most likely related to which of the following class of hypoglycemia-inducing drugs already in clinical use?
A) biguanides
B) meglitinides
C) sulfonylureas
D) thiazolidinediones

Question

Quizplus · Accepted Answer

Thiazolidinediones are a class of drugs that work by activating PPARg, which helps improve insulin sensitivity and lower blood glucose levels in Type 2 diabetes.  The thoiazolidinediones function as agonists for PPARγ

You Are Carrying Out Studies with a Drug to Potentially